ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
- The Indian Council of Medical Research (ICMR) and Pfizer Ltd will set up a centre to combat antimicrobial resistance (AMR) in New Delhi.The joint initiative will implement a series of interventions in three areas namely Planning,Surveillance and Awareness around responsible use of antibiotics.
- The criticism against this collaboration is that it will give Pfizer access not just to doctors but also to policy makers.This is particularly useful for the company since its recent declaration that it will stop sponsoring and gifting doctors for promoting their product.
- The Indian government had also announced National action plan on antimicrobial resistance(NAP-AMR) which focuses on six priority areas which are a) awareness and understanding through education b)communication and training c) strengthening knowledge and evidence through surveillance d)infection prevention and control e) optimised antimicrobial use in animals and food and f) AMR-related research and innovation.
- ICMR is India’s apex scientific body for the formulation, coordination and promotion of biomedical research.It works under Ministry of Health and Family Welfare.
